mortality/aging
• death within 3 months of tamoxifen treatment
|
respiratory system
• small cell lung tumors 2.5 months after tamoxifen treatment
|
• increased proliferation of pulmonary neuroendocrine cells
|
neoplasm
• all mice develop thyroid tumors
|
• increased invasiveness at 2.5 months after tamoxifen treatment
|
• small cell lung tumors 2.5 months after tamoxifen treatment
|
endocrine/exocrine glands
• all mice develop thyroid tumors
|